Top Markets
Coin of the day
Banyan Corp. Banyan Corp.

Banyan Corp.

BNYN
Rang in Aktien #39971
Banyan Corp., operating through its subsidiaries, focuses on franchising... Banyan Corp., operating through its subsidiaries, focuses on franchising chiropractic clinics throughout North America. The company provides extensive support to its franchisees and licensees, including specialized practice development training and assistance tailored for chiropractors. Beyond its franchising activities, Banyan delivers vital diagnostic testing services. A key offering is Nerve Conduction Velocity (NCV) testing, which is administered to patients via healthcare professionals such as doctors and chiropractors. This NCV testing is instrumental in evaluating the transmission of nerve impulses, identifying irregularities within the nervous system, and supplying objective data to substantiate treatment expenses for patients and their insurance providers. Furthermore, Banyan manufactures and markets its proprietary VT3000, an advanced nerve testing system. This system is engineered for the precise diagnosis of neuropathies – conditions affecting the peripheral nerves and spinal regions – alongside nerve irritation and other forms of nervous system damage in patients. Established in 1978, Banyan Corp. maintains its headquarters in Beverly Hills, California.
Aktienkurs
$0.00019
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$286.04K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Banyan Corp. (BNYN)

Kategorie

EPS für Banyan Corp. (BNYN)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Banyan Corp. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Banyan Corp. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber